Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 16,088,900 | 15,787,400 | 15,940,700 | 14,570,600 | 12,688,100 |
| Cost of Goods | 2,493,100 | 2,191,400 | 2,168,000 | 1,860,800 | 2,751,800 |
| Gross Profit | 13,595,800 | 13,596,000 | 13,772,700 | 12,709,800 | 9,936,300 |
| Operating Expenses | 18,041,200 | 19,844,000 | 19,693,900 | 14,536,100 | 13,068,100 |
| Operating Income | -4,445,300 | -6,247,600 | -5,921,200 | -1,825,500 | -3,131,000 |
| Interest Expense | 783,000 | 911,200 | 1,095,600 | 1,295,600 | 1,193,300 |
| Other Income | 109,600 | 301,900 | -3,369,600 | 289,100 | -223,200 |
| Pre-tax Income | -5,118,700 | -6,856,900 | -10,386,400 | -2,832,000 | -4,547,500 |
| Income Tax | 146,400 | -1,770,700 | -6,670,400 | -1,897,000 | -1,605,900 |
| Net Income Continuous | -5,265,100 | -5,086,200 | -3,716,000 | -935,000 | -2,941,600 |
| Net Income Discontinuous | N/A | N/A | -402,900 | 15,914,500 | 6,861,000 |
| Minority Interests | 5,900 | 10,200 | 6,600 | 6,100 | 4,200 |
| Net Income | $-5,271,000 | $-5,096,400 | $-4,125,500 | $14,973,400 | $3,915,200 |
| EPS Basic Total Ops | -16.02 | -15.26 | -13.19 | 38.18 | 10.01 |
| EPS Basic Continuous Ops | -16.02 | -15.26 | -11.99 | -3.17 | -8.64 |
| EPS Basic Discontinuous Ops | N/A | N/A | -1.20 | 41.35 | 18.65 |
| EPS Diluted Total Ops | -16.02 | -15.26 | -13.19 | 38.18 | 10.01 |
| EPS Diluted Continuous Ops | -16.02 | -15.26 | -11.99 | -3.17 | -8.64 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -1.20 | 41.35 | 18.65 |
| EPS Diluted Before Non-Recurring Items | 17.64 | 16.69 | 16.35 | 13.51 | 13.43 |
| EBITDA(a) | $1,764,201 | $523,600 | $1,606,902 | $4,898,898 | $4,355,500 |